SCHEMBL15428153

SCHEMBL15428153

Cc1cc(C)c2c(c1)c1ccccc1c1nc3c(n12)C1CCC3C1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.35
CYP2A6 P11509 1/20 0.35
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15428152 0.82 MEN1 (0.36) BCHEACHE
SCHEMBL17084981 0.79 MAPT (0.33) BCHEACHE
SCHEMBL15427917 0.77 ACHE (0.38) BCHEACHE
SCHEMBL16905528 0.74 MEN1 (0.37) CYP1A2BCHEACHE
SCHEMBL15428154 0.73 RORA (0.38) CYP1A2BCHEACHE
SCHEMBL17084977 0.72 CYP11B2 (0.35) BCHEACHE
SCHEMBL16905598 0.68 LCK (0.36) BCHEACHE
SCHEMBL20627226 0.67 KMT2A (0.39) CYP2A6BCHEACHE
SCHEMBL17084982 0.67 PARP1 (0.37) BCHEACHE
SCHEMBL16905531 0.65 RORA (0.39) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837622-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-05 US disclosed
US-9837622-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-05 US disclosed
US-20150263297-A1 Metal Complexes MERCK PATENT GMBH (DE) 2015-09-17 US disclosed
US-20150263297-A1 Metal Complexes MERCK PATENT GMBH (DE) 2015-09-17 US disclosed
WO-2014008982-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150263297-A1 Metal Complexes SOD1, AP1M1, AP3M1 CYP1A2 3647/4885CYP2A6 3927/4885BCHE 3762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.